111 results Stibbe StartsUP welcomes Dyme Fintech-startup Dyme is the latest company to join the Stibbe StartsUP program. As a finalist of the Accenture Innovation Awards in 2018, Dyme will be able to benefit from legal expertise from Stibbe on a range of issues. Stibbe StartsUP verwelkomt Dyme Fintech-startup Dyme wordt de nieuwe deelnemer van StartsUP, het startup programma van Stibbe. Door deelname aan dit unieke programma kan de finalist van de Accenture Innovation Awards 2018 gebruikmaken van de juridische expertise van het advocatenkantoor Stibbe advises Agendia Stibbe advised Agendia on securing a $35 million investment from funds managed by Athyrium Capital Management. Stibbe advises Aedifica Stibbe advises Aedifica on the acquisition of three healthcare residences for the elderly at Leiden, Oss and Amersfoort. The three residences are operated by ECR/Blueprint Group. Stibbe advises on the equity offering of ProQR Stibbe advised the joint bookrunners Citigroup, Evercore ISI and RBC Capital Markets and the co-managers on the $104.1 million equity offering of ProQR Therapeutics N.V. ("ProQR"). Stibbe advises MRDH Stibbe advised the metropolitan region of Rotterdam and The Hague (MRDH) on a loan of EUR 115 million to companies EBS (13.4 million) and RET (102 million) to buy buses for the concessions Voorne-Putten and Rozenburg and Bus Rotterdam. Webinar: The contraversial Bayer judgment and its potential impact on patent litigation in Europe Philippe Campolini, IP partner at Stibbe in Brussels, acts as panelist in a webinar organised by EPLAW (the European Patent Lawyers Association) on the contraversial Bayer judgment and its potential impact on patent litigation in Europe. Data en financiële instellingen In deze podcast praten Roderik Vrolijk en Frederiek Fernhout van Stibbe in Amsterdam en Joran Iedema van Stibbe StartsUP-deelnemer Dyme over Fintech, PSD2 en het gebruik van data door financiële instellingen. Stibbe advises Aedifica Stibbe's Real Estate Transaction Group advised Aedifica NV, a Belgian listed company investing in healthcare real estate, on the further expansion of its portfolio in the Netherlands. Anya Murphy Junior Associate Brussels Mini-symposium “De accountant – Paard van Troje?” Op dinsdag 21 mei organiseert de afdeling Corporate Criminal Law & Investigations van Stibbe een mini-symposium rond het thema van de accountant als pseudo-opsporingsambtenaar en de controlecliënt als potentiële verdachte. Ignace Vernimme, Floris ten Have and Manuel Campolini are speakers during the Legal Affairs Conference. Ignace Vernimme moderates a roundtable discussion on 'second medical use patents'. Manuel Campolini co-moderates this session. Floris ten Have chairs a session on opportunities and challenges for biosimilar medicine developers. Stibbe advises KBC Securities Stibbe assisted KBC Securities as underwriters on the IPO of ThromboGenics on Euronext Brussels. Stibbe advises worldwide seeds leader Stibbe assisted a worldwide seeds leader in negotiations on cooperation deals with competitors. Stibbe advises pharmaceutical multinational Stibbe assisted a pharmaceutical multinational in complex litigations. Stibbe advises leading plasma protein biotherapeutics company Stibbe advised a plasma protein biotherapeutics company on Belgium's implementation of a new Act on public procurement law that obliges Belgian hospitals to conduct a public procurement process for public contracts for the supply of medicinal products. Stibbe advises on the contemplated IPO of Agendia Stibbe advises biotech company Stibbe advised a leading biotechnology company on the legal aspects of clinical trials development for biotech medicinal products. Pagination Previous page Page 3 Current page 4 Page 5 Page 6 Next page
Stibbe StartsUP welcomes Dyme Fintech-startup Dyme is the latest company to join the Stibbe StartsUP program. As a finalist of the Accenture Innovation Awards in 2018, Dyme will be able to benefit from legal expertise from Stibbe on a range of issues.
Stibbe StartsUP verwelkomt Dyme Fintech-startup Dyme wordt de nieuwe deelnemer van StartsUP, het startup programma van Stibbe. Door deelname aan dit unieke programma kan de finalist van de Accenture Innovation Awards 2018 gebruikmaken van de juridische expertise van het advocatenkantoor
Stibbe advises Agendia Stibbe advised Agendia on securing a $35 million investment from funds managed by Athyrium Capital Management.
Stibbe advises Aedifica Stibbe advises Aedifica on the acquisition of three healthcare residences for the elderly at Leiden, Oss and Amersfoort. The three residences are operated by ECR/Blueprint Group.
Stibbe advises on the equity offering of ProQR Stibbe advised the joint bookrunners Citigroup, Evercore ISI and RBC Capital Markets and the co-managers on the $104.1 million equity offering of ProQR Therapeutics N.V. ("ProQR").
Stibbe advises MRDH Stibbe advised the metropolitan region of Rotterdam and The Hague (MRDH) on a loan of EUR 115 million to companies EBS (13.4 million) and RET (102 million) to buy buses for the concessions Voorne-Putten and Rozenburg and Bus Rotterdam.
Webinar: The contraversial Bayer judgment and its potential impact on patent litigation in Europe Philippe Campolini, IP partner at Stibbe in Brussels, acts as panelist in a webinar organised by EPLAW (the European Patent Lawyers Association) on the contraversial Bayer judgment and its potential impact on patent litigation in Europe.
Data en financiële instellingen In deze podcast praten Roderik Vrolijk en Frederiek Fernhout van Stibbe in Amsterdam en Joran Iedema van Stibbe StartsUP-deelnemer Dyme over Fintech, PSD2 en het gebruik van data door financiële instellingen.
Stibbe advises Aedifica Stibbe's Real Estate Transaction Group advised Aedifica NV, a Belgian listed company investing in healthcare real estate, on the further expansion of its portfolio in the Netherlands.
Mini-symposium “De accountant – Paard van Troje?” Op dinsdag 21 mei organiseert de afdeling Corporate Criminal Law & Investigations van Stibbe een mini-symposium rond het thema van de accountant als pseudo-opsporingsambtenaar en de controlecliënt als potentiële verdachte.
Ignace Vernimme, Floris ten Have and Manuel Campolini are speakers during the Legal Affairs Conference. Ignace Vernimme moderates a roundtable discussion on 'second medical use patents'. Manuel Campolini co-moderates this session. Floris ten Have chairs a session on opportunities and challenges for biosimilar medicine developers.
Stibbe advises KBC Securities Stibbe assisted KBC Securities as underwriters on the IPO of ThromboGenics on Euronext Brussels.
Stibbe advises worldwide seeds leader Stibbe assisted a worldwide seeds leader in negotiations on cooperation deals with competitors.
Stibbe advises pharmaceutical multinational Stibbe assisted a pharmaceutical multinational in complex litigations.
Stibbe advises leading plasma protein biotherapeutics company Stibbe advised a plasma protein biotherapeutics company on Belgium's implementation of a new Act on public procurement law that obliges Belgian hospitals to conduct a public procurement process for public contracts for the supply of medicinal products.
Stibbe advises biotech company Stibbe advised a leading biotechnology company on the legal aspects of clinical trials development for biotech medicinal products.